Mark A. Velleca, President and CEO at G1 Therapeutics, Inc. (GTHX), sold 7,500 shares at $20.00 ($150K) on 2018-02-15, disclosed to the SEC on 2018-02-16.
Open-market sale of $150k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2022-09-22 | $270K | — | Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |